Experimental studies in models of non-alcoholic steatohepatitis (NASH) and neurodegenerative diseases have demonstrated that caffeine downregulates toll-like receptor 4 (TLR4)-mediated signaling, a key initiator of innate immune responses. This evidence concerns the gene TLR4 and neurodegenerative disease.